Antonin (Tony) de Fougerolles

de Fourgerolles is CEO of Evox Therapeutics based in Oxford, UK.  Previously, he was chief scientific officer (CSO) of Ablynx where he led non-clinical $&D operations. He was founding CSO at Moderna Therapeutics, where he was the inventor of the mRNA chemistry and delivery systems that form the basis of both approved COVID-19 mRNA vaccines. Prior to that, he was CSO of immuno-oncology company Tolerx Inc., and vice president of research at Alnylam where he helped develop RNA interference as a new drug modality.

  • March 2023

Added to: Chimeron Bio - Philadelphia, PA

Chimeron Bio is an RNA company developing self-amplifying RNA vaccines and therapeutics.